mh048
Showing 1 - 1 of 1
Relapsed/Refractory B-cell Malignancies Trial in Hangzhou (MH048)
Recruiting
- Relapsed/Refractory B-cell Malignancies
- MH048
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospita,Medicine School of Zhejiang Univers
Aug 31, 2021